通过药理干预措施缓解与活性氧物种 (ROS) 和蛋白质聚合相关的糖尿病
Giulia Bennici1, Hanan Almahasheer2, Mawadda Alghrably1
1Division of Biological and Environmental Sciences and Engineering (BESE), King Abdullah University of Science and Technology (KAUST) Thuwal 23955-6900 Saudi Arabia mariusz.jaremko@kaust.edu.sa.
RSC advances
|May 30, 2024
概括
反应性氧物种和蛋白质聚合通过破坏细胞和损害胰岛素信号传递,导致糖尿病. 了解这些分子机制是开发新的糖尿病治疗方法的关键.
科学领域:
- 内分泌学和新陈代谢学
- 分子生物学分子生物学
- 病理生理学 病理生理学
背景情况:
- 糖尿病是一种日益严重的全球健康问题,在2021年有5.29亿例,主要是2型糖尿病.
- 目前的管理重点是减缓并发症,但需要新的生物标志物和治疗方法.
- 新兴的研究表明,反应性氧物种 (ROS) 和蛋白质聚合在糖尿病病变发生过程中的相互作用.
研究的目的:
- 审查ROS诱导的细胞损伤和糖尿病中的蛋白质聚合的分子机制.
- 探索ROS在氧化应激中的作用及其对细胞信号传递的影响.
- 检查蛋白质聚合如何影响细胞功能和胰岛素信号传递.
主要方法:
- 关于目前对糖尿病分子机制的理解的文献综述.
- 讨论ROS在氧化应激和细胞损伤中的作用.
- 探索蛋白质聚合对细胞功能和胰岛素信号传递的影响.
主要成果:
- 氧化氧化物是糖尿病中氧化应激的关键媒介,影响细胞组件和信号通路.
- 蛋白质聚合会损害细胞功能和胰岛素信号传递,导致疾病的进展.
- ROS和蛋白质聚合的协同效应促进β细胞功能障碍和胰岛素抵抗.
结论:
- 了解ROS和蛋白质聚合之间的分子相互作用对于糖尿病管理至关重要.
- 针对ROS诱导的损伤和蛋白质聚合,为糖尿病提供了潜在的治疗策略.
- 对这些机制的进一步研究可能会导致新的生物标志物和糖尿病治疗方法.
相关概念视频
Diabetes: Management and Pharmacotherapy
260
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
260
Oral Hypoglycemic Agents: Biguanides and Glitazones
189
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
189
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Electron Transport Chain: Complex I and II
13.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.0K
Diabetes: Symptoms, Diagnosis, and Complications
523
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
523


